Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation
Peng‐Chieh Chen(Brigham and Women's Hospital), Raju Kucherlapati(Harvard University), Hiroko Wakimoto(Brigham and Women's Hospital), Roderick T. Bronson(Harvard University), Amy E. Roberts(Boston Children's Hospital), Christine E. Seidman(Harvard University), David A. Conner(Howard Hughes Medical Institute), Toshiyuki Araki(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Benjamin G. Neel(New York University), Jonathan G. Seidman(Harvard University)
Cited by 133
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k